Brenda Anne Atkinson CASAC

Recommended Articles

• Alternative Treatments for Genital Herpes

  Genital herpes affects more than 10 percent of the population in the United States. Genital herpes is spread through sexual intercourse. It is mostly caused by the herpes simplex virus type two, although it can also be caused by herpes simplex virus type 1, the cause of oral herpes or cold...

• The History of Rheumatoid Arthritis

  Introduction Rheumatoid arthritis causes inflammation of the joints and other body areas. It is an autoimmune disease and its symptoms include:...

• 10 Tips on Living with Insomnia

  .................................................................................................................................................................................................................................................................................................................................................................................People...

• What Is Chronic Sinusitis: Symptoms, Causes, and Treatment

  IntroductionChronic sinusitis is the inflammation of the sinuses that tend to persist for 12 weeks or more, despite treatment attempts. Another term for chronic sinusitis is chronic rhinosinusitis, which causes mucus buildup due to an impaired drainage of the sinuses. People with chronic sinusitis...

• What to Expect After a Cholecystectomy

  In case you have problems with your gallbladder and there is a need for it to be removed, you will experience unusual and uncomfortable symptoms while trying to adapt to a new life without a gallbladder. Obviously, when your gallbladder is removed, bile can't be stored like before since it is meant...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...